QQ客服 官方微博 反馈留言

	Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition
	Yang, L.; Zhang, Y.; Shan, W.; Hu, Z.; Yuan, J.; Pi, J.; Wang, Y.; Fan, L.; Tang, Z.; Li, C.
刊名	Science Translational Medicine
	2017
卷号	Vol.9 No.400
ISSN号	1946-6234
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1820869
专题	四川大学
作者单位	1.Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China 2.g Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States 3.h Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States 4.Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, United States 5.Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States 6.a Center for Research on Reproduction and Women's Health, University of Pennsylvania, Philadelphia, PA, United States 7.Department of Obstetrics and Gynecology, West China Medical School, Sichuan University, Chengdu, China 8.f Wistar Institute, Philadelphia, PA, United States
推荐引用方式 GB/T 7714	Yang, L.,Zhang, Y.,Shan, W.,et al. Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition[J]. Science Translational Medicine,2017,Vol.9 No.400.
APA	Yang, L..,Zhang, Y..,Shan, W..,Hu, Z..,Yuan, J..,...&Zhang, L..(2017).Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition.Science Translational Medicine,Vol.9 No.400.
MLA	Yang, L.,et al."Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition".Science Translational Medicine Vol.9 No.400(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。